vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Ramaco Resources, Inc. (METC). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $121.0M, roughly 1.6× Ramaco Resources, Inc.). Ramaco Resources, Inc. runs the higher net margin — -11.0% vs -14.6%, a 3.6% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -27.7%). Ramaco Resources, Inc. produced more free cash flow last quarter ($-17.5M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -22.7%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Ramaco Resources, Inc. is a U.S.-based mining company focused on high-grade metallurgical coal production. It operates mining assets across the Appalachian region, supplying products to global steel manufacturing and industrial clients, with core operations centered on sustainable low-cost metallurgical coal extraction and distribution.
AXSM vs METC — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $121.0M |
| Net Profit | $-28.6M | $-13.3M |
| Gross Margin | — | 15.8% |
| Operating Margin | -13.8% | -12.0% |
| Net Margin | -14.6% | -11.0% |
| Revenue YoY | 65.0% | -27.7% |
| Net Profit YoY | 61.9% | -5468.2% |
| EPS (diluted) | $-0.55 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | — | ||
| Q3 25 | $171.0M | $121.0M | ||
| Q2 25 | $150.0M | $153.0M | ||
| Q1 25 | $121.5M | $134.7M | ||
| Q4 24 | $118.8M | $170.9M | ||
| Q3 24 | $104.8M | $167.4M | ||
| Q2 24 | $87.2M | $155.3M | ||
| Q1 24 | $75.0M | $172.7M |
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-47.2M | $-13.3M | ||
| Q2 25 | $-48.0M | $-14.0M | ||
| Q1 25 | $-59.4M | $-9.5M | ||
| Q4 24 | $-74.9M | $3.9M | ||
| Q3 24 | $-64.6M | $-239.0K | ||
| Q2 24 | $-79.3M | $5.5M | ||
| Q1 24 | $-68.4M | $2.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 15.8% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 15.2% | ||
| Q4 24 | — | 20.4% | ||
| Q3 24 | — | 19.5% | ||
| Q2 24 | — | 21.0% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -13.8% | — | ||
| Q3 25 | -27.0% | -12.0% | ||
| Q2 25 | -24.5% | -9.1% | ||
| Q1 25 | -46.9% | -8.9% | ||
| Q4 24 | -61.1% | 3.7% | ||
| Q3 24 | -59.8% | 1.0% | ||
| Q2 24 | -89.5% | 3.5% | ||
| Q1 24 | -89.7% | 1.9% |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -27.6% | -11.0% | ||
| Q2 25 | -32.0% | -9.1% | ||
| Q1 25 | -48.9% | -7.0% | ||
| Q4 24 | -63.1% | 2.3% | ||
| Q3 24 | -61.7% | -0.1% | ||
| Q2 24 | -91.0% | 3.6% | ||
| Q1 24 | -91.1% | 1.2% |
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $-0.94 | — | ||
| Q2 25 | $-0.97 | — | ||
| Q1 25 | $-1.22 | — | ||
| Q4 24 | $-1.54 | $0.06 | ||
| Q3 24 | $-1.34 | $-0.03 | ||
| Q2 24 | $-1.67 | $0.08 | ||
| Q1 24 | $-1.44 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $193.8M |
| Total DebtLower is stronger | — | $116.3M |
| Stockholders' EquityBook value | $88.3M | $526.9M |
| Total Assets | $689.8M | $849.7M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | $193.8M | ||
| Q2 25 | $303.0M | $28.1M | ||
| Q1 25 | $300.9M | $43.5M | ||
| Q4 24 | $315.4M | $33.0M | ||
| Q3 24 | $327.3M | $22.9M | ||
| Q2 24 | $315.7M | $27.6M | ||
| Q1 24 | $331.4M | $30.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $116.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $88.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $88.3M | — | ||
| Q3 25 | $73.7M | $526.9M | ||
| Q2 25 | $73.1M | $347.4M | ||
| Q1 25 | $53.2M | $355.2M | ||
| Q4 24 | $57.0M | $362.8M | ||
| Q3 24 | $92.9M | $361.8M | ||
| Q2 24 | $102.9M | $366.1M | ||
| Q1 24 | $144.0M | $372.3M |
| Q4 25 | $689.8M | — | ||
| Q3 25 | $669.3M | $849.7M | ||
| Q2 25 | $639.8M | $674.6M | ||
| Q1 25 | $596.7M | $685.7M | ||
| Q4 24 | $568.5M | $674.7M | ||
| Q3 24 | $561.5M | $645.4M | ||
| Q2 24 | $548.2M | $659.2M | ||
| Q1 24 | $545.7M | $674.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $-1.4M |
| Free Cash FlowOCF − Capex | $-18.7M | $-17.5M |
| FCF MarginFCF / Revenue | -9.6% | -14.5% |
| Capex IntensityCapex / Revenue | 0.0% | 13.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $-24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $1.0M | $-1.4M | ||
| Q2 25 | $-32.4M | $-4.3M | ||
| Q1 25 | $-43.4M | $26.0M | ||
| Q4 24 | $-26.2M | $15.7M | ||
| Q3 24 | $-18.6M | $37.4M | ||
| Q2 24 | $-30.1M | $34.4M | ||
| Q1 24 | $-53.5M | $25.2M |
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | $-17.5M | ||
| Q2 25 | $-32.4M | $-19.8M | ||
| Q1 25 | $-43.7M | $7.6M | ||
| Q4 24 | $-26.2M | $5.1M | ||
| Q3 24 | $-18.7M | $25.6M | ||
| Q2 24 | $-30.2M | $20.3M | ||
| Q1 24 | $-53.6M | $6.5M |
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | -14.5% | ||
| Q2 25 | -21.6% | -13.0% | ||
| Q1 25 | -36.0% | 5.6% | ||
| Q4 24 | -22.1% | 3.0% | ||
| Q3 24 | -17.9% | 15.3% | ||
| Q2 24 | -34.6% | 13.1% | ||
| Q1 24 | -71.4% | 3.7% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 13.3% | ||
| Q2 25 | 0.0% | 10.2% | ||
| Q1 25 | 0.3% | 13.7% | ||
| Q4 24 | 0.0% | 6.2% | ||
| Q3 24 | 0.1% | 7.0% | ||
| Q2 24 | 0.1% | 9.1% | ||
| Q1 24 | 0.1% | 10.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.06× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 6.21× | ||
| Q1 24 | — | 12.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
METC
| Export Coal Revenues | $73.0M | 60% |
| Domestic Coal Revenues | $48.0M | 40% |
